OBJECTIVE	To investigate patient-reported health-related quality of life ( HRQoL ) in data collected from a multinational randomized double-blind controlled trial comparing oral mesalazine ( 4 g ) + topical mesalazine enema ( 1 g ) to oral mesalazine alone ( 4 g ) .\